Claritev Corporation (CTEV) Stock

About Claritev Corporation

Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.

Claritev Corporation is led by CEO Travis S. Dalton, publicly traded since 2020.

Claritev Corporation (CTEV) stock trades at $21.73 with a market capitalization of $370.45M. The stock is valued at a price-to-earnings (P/E) ratio of -1.25, price-to-book of -1.50, price-to-sales of 0.38. Over the past 52 weeks the stock has ranged between $11.50 and $74.07, and currently trades 70.7% below its 52-week high.

On profitability, Claritev Corporation generates a return on equity (ROE) of 205.84% — well above the market average, a sign of a high-quality business, return on capital employed of 0.90%, an operating margin of 4.66%, a net profit margin of -29.27%.

Official website: www.claritev.com